Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | DDO | Q99489 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | ATP4A | P20648 | 1/20 | 0.32 |
| ▸ | ATP4B | P51164 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7060893 | 0.83 | LIPG (0.33) | GABRA1GABRB2TLR8KCNH2 | |
| SCHEMBL4737660 | 0.82 | — | — | |
| SCHEMBL7213697 | 0.81 | — | — | |
| SCHEMBL7616893 | 0.81 | GABRA1 (0.43) | GABRA1GABRB2ELANE | |
| SCHEMBL18765144 | 0.78 | GAA (0.43) | PLA2G2AKDM4EALDH1A1 | |
| SCHEMBL8474445 | 0.78 | — | — | |
| SCHEMBL433019 | 0.77 | CYP3A4 (0.42) | DAOKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL1079894 | 0.77 | GABRA1 (0.40) | GABRA1GABRB2HTR1AMAPTKDM4E | |
| SCHEMBL2158571 | 0.76 | SLC6A4 (0.36) | HTR1AKCNH2 | |
| SCHEMBL6032884 | 0.75 | CTRC (0.31) | HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117242066-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-12-15 | — | — | CN | claimed |
| EP-3174871-A1 | BICYCLIC ARYLCARBOXYLIC ACID AMIDES AND THEIR USE AS HERBICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2017-06-07 | — | — | EP | claimed |
| WO-2016016107-A1 | BICYCLIC ARYLCARBOXYLIC ACID AMIDES AND THEIR USE AS HERBICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-02-04 | — | — | WO | claimed |
| EP-2903981-A1 | 1,2,4-TRIAZINE-3,5-DIONE-6-CARBOXAMIDES AND USE THEREOF AS HERBICIDE | Bayer CropScience AG (DE) | 2015-08-12 | — | — | EP | claimed |
| EP-2686316-B1 | N-(1,2,5-OXADIAZOL-3-YL)PYRIDINECARBOXAMIDES AND USE THEREOF AS HERBICIDES | BAYER IP GMBH (DE) | 2015-04-22 | — | — | EP | claimed |
| EP-2844650-A1 | 6-PYRIDONE-2-CARBAMOYL-AZOLES AND THEIR USE AS HERBICIDES | Bayer CropScience AG (DE) | 2015-03-11 | — | — | EP | claimed |
| WO-2015007633-A1 | 6-AZINONE-2-CARBONYL DERIVATIVES AND THEIR USE AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2015-01-22 | — | — | WO | claimed |
| WO-2015007632-A1 | URACIL-5-CARBOXAMIDES AND THEIR USE AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2015-01-22 | — | — | WO | claimed |
| WO-2014086737-A1 | CONDENSED 2-PYRIDONE-3-CARBOXAMIDES AND THE USE THEREOF AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2014-06-12 | — | — | WO | claimed |
| WO-2014053473-A1 | 1,2,4-TRIAZINE-3,5-DIONE-6-CARBOXAMIDES AND USE THEREOF AS HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2014-04-10 | — | — | WO | claimed |
| JP-4728259-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| US-20070167482-A1 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors | ALTANA PHARMA AG (DE) | 2007-07-19 | — | — | US | claimed |
| EP-1720835-A1 | NOVEL GUANIDINYL-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AS EFFECTIVE PHOSPHODIESTERASE (PDE) 4 INHIBITORS | Altana Pharma AG (DE) | 2006-11-15 | — | — | EP | claimed |
| US-20060116518-A1 | Novel phenanthridines | ALTANA PHARMA AG (DE) | 2006-06-01 | — | — | US | claimed |
| EP-1581533-A2 | NOVEL BENZONAPHTHYRIDINES | ALTANA Pharma AG (DE) | 2005-10-05 | — | — | EP | claimed |
| WO-2004018465-A9 | BENZONAPHTHYRIDINES WITH PDE 3/4 INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2005-09-15 | — | — | WO | claimed |
| WO-2005077906-A1 | NOVEL GUANIDINYL-SUBSTITUTED HYDROXY-6-PHENYLPHENENTHRIDINES AS EFFECTIVE PHOSPHODIESTERASE (PDE) 4 INHIBITORS | ALTANA PHARMA AG (DE) | 2005-08-25 | — | — | WO | claimed |
| EP-1537086-A2 | NOVEL PHENANTHRIDINES | ALTANA Pharma AG (DE) | 2005-06-08 | — | — | EP | claimed |
| WO-2004018431-A2 | NOVEL PHENANTHRIDINES | ALTANA PHARMA AG (DE) | 2004-03-04 | — | — | WO | claimed |
| WO-2004018465-A2 | BENZONAPHTHYRIDINES WITH PDE 3/4 INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2004-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167482-A1 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors | PDE4A, PDE3A, PDE4B | GABRA1 3401/4885GABRB2 3693/4885DAO 1312/4885 |
| US-20060116518-A1 | Novel phenanthridines | PDE4A, PDE4B, PDE3A | GABRA1 3620/4885GABRB2 4096/4885DAO 2829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.